Apr 26, 2026, 11:42
FDA Update on Hormone Therapy Safety Warnings – JAMA
JAMA shared a post on LinkedIn:
“Perspective: FDA removal of most black box warnings for menopausal hormone therapy enables individualized menopause symptom management; estrogen-only therapy retains a warning for endometrial cancer risk in women with a uterus.”
Title: Opportunity for Improved Menopausal Hormone Therapy Prescribing
Authors: Deborah Bartz, Ananya Tadikonda, JoAnn E. Manson
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Sep 14, 2026, 18:11Mahantesh Karoshi: Any Deep Myometrial Scar Needs Obstetric Planning in a Later Pregnancy
-
Sep 14, 2026, 18:08Smita Rana: Can Stress Affect Female Fertility?
-
Sep 14, 2026, 18:05Lucy Froese: Accepting That IVF Could Be My Path to Becoming a Mum Felt Enormous…
-
Sep 14, 2026, 18:01Jeffrey Deaton: 17-Minute Episode of Becker’s Healthcare Podcast on Leadership and the Future of Fertility Care
-
Sep 14, 2026, 17:58Esther Eleboh: 1 of the Most Mind-Blowing Things I’ve Witnessed in the IVF Laboratory…
-
Sep 14, 2026, 17:55Bhumika: What Happens If 2 Sperm Fertilize 1 Oocyte?
-
Sep 14, 2026, 17:48Khalil Faaed: We Can Grade an Embryo, but Can We Really Predict Its Future?
-
Sep 14, 2026, 17:45Akanksha Khubbar: A Small Step Towards Smarter IVF Laboratories
-
Sep 14, 2026, 17:43Karthik Raj: Fertility Preservation Beyond Egg Freezing